课题基金 / 基金详情

项目摘要

项目成果

DOLORES Jean TAKEMOTO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
All tissues must accommodate stress and growth signals in order to survive. The lens must also function under natural hypoxia, a condition which is so detrimental in heart and brain that one result is ischemic stroke. Ischemic damage is propagated through the gap junction protein, Cx43, and it is protein kinase C (PKC) epsilon which provides protection from damage in heart (1). In contrast, we have found that the lens contains two stress switch PKC isoforms, PKC gamma (PKCγ) and PKC epsilon (PKCε), which both play a stress protection role in the lens (2). During oxidative stress the PKCγ may function to inhibit gap junction proteins, Cx43, Cx50 and Cx46. In contrast, the PKCε is activated by hypoxia and is always found in the mitochondria. The long-term objective of our research is to determine how PKCs protect the lens from cataract formation. PKCγ and PKCε are both part of a large group of stress-switch C1B-containing proteins. C1B domains are zinc-finger/cysteine-rich domains which can be activated by cellular regulatory signals. The overall hypothesis of this proposal is: The lens, which thrives under natural hypoxia, contains two stressswitch PKC isoforms, PKCγ and PKCε, which provide protection during differentiation, hypoxia, and oxidative stress. We have previously reported that oxidative stress signals, such as hydrogen peroxide or the growth factor, IGF-1, activate lens PKCγ and cause the inhibition of the gap junction proteins, Cx43, Cx50, and Cx46, and protection of the lens from oxidative stress and cataracts. In contrast, we find that PKCε is not activated under these same conditions but is activated only by hypoxia (2). The hypoxia-driven activation of PKCε results in translocation to the lens mitochondria and activation of lens mitochondrial cytochrome C oxidase IV (cytIV) and in increased cytIV activity (3). We hypothesize that hypoxia induced activation of cytIV may help to prevent mitochondrial-driven apoptosis which could normally occur under hypoxic conditions in the differentiating lens. Thus, these two PKC isoforms protect the lens through phosphorylation of their respective targets, gap junction proteins (PKCγ targets) and mitochondrial cytIV (PKCε target).
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
NMR structure/function relationships of peptides corresponding to the C1B1 Region of PKC gamma.
PKC gamma 的 C1B1 区域对应的肽的 NMR 结构/功能关系。
DOI: 10.2174/092986610789909485
发表时间: 2010
期刊: Protein and peptide letters
影响因子: 1.6
作者: [Lauer,Jason, Banerjee,Debarshi, Shanks,Denton, Dai,Huaien, Gong,Yu-Xi, Prakash,Om, Takemoto,Dolores]
通讯作者: Takemoto,Dolores
DOI: --
发表时间: 2001-10
期刊: Molecular vision
影响因子: 2.2
作者: [S. Saleh;L. Takemoto;D. Zoukhri;D. Takemoto]
通讯作者: S. Saleh;L. Takemoto;D. Zoukhri;D. Takemoto
DOI: --
发表时间: 2007-05
期刊: Molecular Vision
影响因子: 2.2
作者: [Yun Mo;Micheal E. Barnett;D. Takemoto;H. Davidson;U. Kompella]
通讯作者: Yun Mo;Micheal E. Barnett;D. Takemoto;H. Davidson;U. Kompella
The interaction and phosphorylation of tropomodulin by protein kinase Calpha in N/N 1003A lens epithelial cells.
N/N 1003A 晶状体上皮细胞中蛋白激酶 Cα 与原调节蛋白的相互作用和磷酸化。
DOI: --
发表时间: 2002
期刊: Molecular vision [electronic resource].
影响因子: --
作者: [Wagner,LynnM, Fowler,VeliaM, Takemoto,DoloresJ]
通讯作者: Takemoto,DoloresJ
9
    Expression of Therapeutic Proteins in the Whole Lens
    • 批准号:
      7087723
    • 项目类别:
    • 资助金额:
      $14.26万
    • 财政年份:
      2004
    • 负责人:
      DOLORES Jean TAKEMOTO
    • 依托单位:
    Expression of Therapeutic Proteins in the Whole Lens
    • 批准号:
      6804864
    • 项目类别:
    • 资助金额:
      $14.6万
    • 财政年份:
      2004
    • 负责人:
      DOLORES Jean TAKEMOTO
    • 依托单位:
    Expression of Therapeutic Proteins in the Whole Lens
    • 批准号:
      6928457
    • 项目类别:
    • 资助金额:
      $14.6万
    • 财政年份:
      2004
    • 负责人:
      DOLORES Jean TAKEMOTO
    • 依托单位:
    Protein Kinase C Gamma in the Lens
    • 批准号:
      7229429
    • 项目类别:
    • 资助金额:
      $31.9万
    • 财政年份:
      2001
    • 负责人:
      DOLORES Jean TAKEMOTO
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: